NCT00417274View on ClinicalTrials.gov

Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

31

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions

Prostatic Cancer

Interventions

DRUG

Quinacrine

100 mg daily

Sponsors

Lead Sponsor

Cleveland BioLabs

All Listed Sponsors

lead

Cleveland BioLabs

INDUSTRY